Author

João Sabino

COOKING METHODS ONLY NEGLIGIBLY AFFECT DIETARY FIBER CONTENT AND COMPOSITION
COOKING METHODS ONLY NEGLIGIBLY AFFECT DIETARY FIBER CONTENT AND COMPOSITION

VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS
VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

João Sabino  et al.

ATOPIC PREDISPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW
ATOPIC PREDISPOSITION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

João Sabino  et al.

DISEASE ACCEPTANCE, BUT NOT PERCEIVED CONTROL, IS UNIQUELY ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE-RELATED DISABILITY
DISEASE ACCEPTANCE, BUT NOT PERCEIVED CONTROL, IS UNIQUELY ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE-RELATED DISABILITY

João Sabino  et al.

EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS
EFFECTIVENESS OF USTEKINUMAB AS INDUCTION THERAPY FOR CHRONIC ANTIBIOTIC REFRACTORY POUCHITIS

João Sabino  et al.

COVID19 VACCINATION COVERAGE IN FLEMISH PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES
COVID19 VACCINATION COVERAGE IN FLEMISH PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES

João Sabino  et al.

COOKING METHODS ONLY NEGLIGIBLY AFFECT DIETARY FIBER CONTENT AND COMPOSITION
COOKING METHODS ONLY NEGLIGIBLY AFFECT DIETARY FIBER CONTENT AND COMPOSITION

João Sabino  et al.

MULTIDISCIPLINARY BELGIAN POSITION STATEMENT ON THE MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED COLITIS
MULTIDISCIPLINARY BELGIAN POSITION STATEMENT ON THE MANAGEMENT OF IMMUNE CHECKPOINT INHIBITOR ASSOCIATED COLITIS

João Sabino  et al.

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment
ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

João Sabino  et al.

NEW TOOLS FOR PREDICTING SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB
NEW TOOLS FOR PREDICTING SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

João Sabino  et al.

Item 1 - 10 / 10
1